vs
Side-by-side financial comparison of enCore Energy Corp. (EU) and Kymera Therapeutics, Inc. (KYMR). Click either name above to swap in a different company.
enCore Energy Corp. is the larger business by last-quarter revenue ($12.4M vs $11.5M, roughly 1.1× Kymera Therapeutics, Inc.). enCore Energy Corp. runs the higher net margin — -173.9% vs -667.6%, a 493.7% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-60.6M).
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.
EU vs KYMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.4M | $11.5M |
| Net Profit | $-21.5M | $-76.6M |
| Gross Margin | 37.9% | — |
| Operating Margin | -135.9% | -736.8% |
| Net Margin | -173.9% | -667.6% |
| Revenue YoY | — | -55.3% |
| Net Profit YoY | — | -82.1% |
| EPS (diluted) | $-0.11 | $-0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.4M | — | ||
| Q3 25 | $8.9M | — | ||
| Q2 25 | $3.7M | $11.5M | ||
| Q1 25 | $18.2M | $22.1M | ||
| Q4 24 | — | $7.4M | ||
| Q2 24 | — | $25.6M | ||
| Q1 24 | — | $10.3M | ||
| Q4 23 | — | $47.9M |
| Q4 25 | $-21.5M | — | ||
| Q3 25 | $-4.8M | — | ||
| Q2 25 | $-6.3M | $-76.6M | ||
| Q1 25 | $-24.2M | $-65.6M | ||
| Q4 24 | — | $-70.8M | ||
| Q2 24 | — | $-42.1M | ||
| Q1 24 | — | $-48.6M | ||
| Q4 23 | — | $-14.4M |
| Q4 25 | 37.9% | — | ||
| Q3 25 | 43.8% | — | ||
| Q2 25 | 30.8% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | -135.9% | — | ||
| Q3 25 | -158.2% | — | ||
| Q2 25 | -526.1% | -736.8% | ||
| Q1 25 | -85.7% | -336.8% | ||
| Q4 24 | — | -1092.2% | ||
| Q2 24 | — | -198.5% | ||
| Q1 24 | — | -562.2% | ||
| Q4 23 | — | -40.3% |
| Q4 25 | -173.9% | — | ||
| Q3 25 | -53.7% | — | ||
| Q2 25 | -172.7% | -667.6% | ||
| Q1 25 | -132.9% | -296.7% | ||
| Q4 24 | — | -956.9% | ||
| Q2 24 | — | -164.0% | ||
| Q1 24 | — | -472.0% | ||
| Q4 23 | — | -30.0% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.03 | $-0.95 | ||
| Q1 25 | $-0.13 | $-0.82 | ||
| Q4 24 | — | $-0.89 | ||
| Q2 24 | — | $-0.58 | ||
| Q1 24 | — | $-0.69 | ||
| Q4 23 | — | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $335.8M |
| Total DebtLower is stronger | $110.0M | — |
| Stockholders' EquityBook value | $229.2M | $971.5M |
| Total Assets | $430.4M | $1.1B |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | — | ||
| Q3 25 | $91.9M | — | ||
| Q2 25 | $26.9M | $335.8M | ||
| Q1 25 | $29.7M | $90.0M | ||
| Q4 24 | — | $120.3M | ||
| Q2 24 | — | $67.6M | ||
| Q1 24 | — | $93.5M | ||
| Q4 23 | — | $110.0M |
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | $229.2M | — | ||
| Q3 25 | $248.6M | — | ||
| Q2 25 | $264.7M | $971.5M | ||
| Q1 25 | $267.9M | $786.2M | ||
| Q4 24 | — | $835.6M | ||
| Q2 24 | — | $684.9M | ||
| Q1 24 | — | $711.2M | ||
| Q4 23 | — | $395.0M |
| Q4 25 | $430.4M | — | ||
| Q3 25 | $441.9M | — | ||
| Q2 25 | $359.4M | $1.1B | ||
| Q1 25 | $362.6M | $918.3M | ||
| Q4 24 | — | $978.0M | ||
| Q2 24 | — | $826.0M | ||
| Q1 24 | — | $868.3M | ||
| Q4 23 | — | $575.8M |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.9M | $-59.9M |
| Free Cash FlowOCF − Capex | $7.2M | $-60.6M |
| FCF MarginFCF / Revenue | 57.8% | -527.9% |
| Capex IntensityCapex / Revenue | 46.7% | 6.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.0M | $-250.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.9M | — | ||
| Q3 25 | $-20.3M | — | ||
| Q2 25 | $-9.9M | $-59.9M | ||
| Q1 25 | $-7.7M | $-79.2M | ||
| Q4 24 | — | $-61.8M | ||
| Q2 24 | — | $-42.9M | ||
| Q1 24 | — | $-39.6M | ||
| Q4 23 | — | $8.0M |
| Q4 25 | $7.2M | — | ||
| Q3 25 | $-26.3M | — | ||
| Q2 25 | $-14.1M | $-60.6M | ||
| Q1 25 | $-11.7M | $-79.6M | ||
| Q4 24 | — | $-62.7M | ||
| Q2 24 | — | $-47.6M | ||
| Q1 24 | — | $-47.0M | ||
| Q4 23 | — | $-3.6M |
| Q4 25 | 57.8% | — | ||
| Q3 25 | -296.6% | — | ||
| Q2 25 | -385.2% | -527.9% | ||
| Q1 25 | -64.1% | -360.3% | ||
| Q4 24 | — | -848.3% | ||
| Q2 24 | — | -185.7% | ||
| Q1 24 | — | -456.8% | ||
| Q4 23 | — | -7.5% |
| Q4 25 | 46.7% | — | ||
| Q3 25 | 68.0% | — | ||
| Q2 25 | 115.1% | 6.1% | ||
| Q1 25 | 21.7% | 2.1% | ||
| Q4 24 | — | 12.7% | ||
| Q2 24 | — | 18.3% | ||
| Q1 24 | — | 72.0% | ||
| Q4 23 | — | 24.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
